News
-
-
-
-
-
-
-
-
-
REGULATED PRESS RELEASE
NFL Biosciences presents its 2024 annual results and provides an update on its clinical program
NFL Biosciences presents 2024 annual results and clinical program update. NFL-101 phase 2 efficacy, innovative action with CEA, Phase 3 study plans, financing strategy, low cash burn until Q4 2025 -